摘要
目的探讨联合雾化吸入普米克令舒、博利康尼对轻中度支气管哮喘的治疗作用。方法51例支气管哮喘患者随机分为对照组(25例)和治疗组(26例)。两组均予吸氧、抗感染、静脉氨茶碱及对症等治疗。治疗组加用普米克令舒及博利康尼氧气雾化吸入。两组均于治疗前及治疗7天后测定肺功能及动脉血气。结果两组肺功能及PaO2较治疗前均有明显改善(P<0.01或P<0.05)。结论联合雾化吸入普米克令舒和博利康尼治疗轻、中度支气管哮喘安全有效,并有协同作用。
Objective To investigate the therapeutical effect of combined Inhale pulmicort respules with bricanyl in the mild-to- moderate persistent asthma. Methods 51 patients with mild-to-moderate persistent asthma were divided into tow groups （the treatment group and the control group）at random. The two groups were received inhale oxygen, anti -infection, intravenous aminophylline and symptom therapy, and the treatment group attached to inhale pulmicort respules and bricanyl with oxygen. All patients underwent pulmonary function test and arterial blood gas analysis respectively before treatment and 7 days after therapy. Results There were significant improvement of all pulmonary function and PaO2 of tow groups after therapy（P 〈0. 01 or P 〈0. 05） ;The treatment group efficient rate were significantly superior to the control group （ P = 0. 023 ）. After therapy, FEV1, FEV1/FVC, percent predicted FEV1 and PaO2 were much higher in the treatment group than in the control group（ P are 0. 030,0. 033,0. 015 and 0. 042）. Conclusions Combined Inhale pulmicort respules with bricanyl in the mild-to-moderate persistent asthma is safe and effective. There are several positive interactions between pulmicort respules and bricanyl.
出处
《临床肺科杂志》
2008年第3期276-277,共2页
Journal of Clinical Pulmonary Medicine
